Spoken Alpha
COMPASS Pathways plc
COMPASS Pathways develops COMP360, a proprietary psilocybin formulation, to treat serious mental health conditions including treatment-resistant depression and post-traumatic stress disorder.
COMPASS Pathways plc is a Healthcare company operating in Medical Care Facilities with a $1.99B market cap.
Most recent reported earnings: Q3 FY2026 (Nov 2, 2026).
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CMPS.
$ curl https://api.spokenalpha.com/v1/companies/CMPSFAQ
Spoken Alpha indexes CMPS's earnings call transcripts at https://spokenalpha.com/companies/CMPS. Each call links to attributed speakers and parsed analyst Q&A. COMPASS Pathways plc's own investor relations page is at https://ir.compasspathways.com/overview/default.aspx.
COMPASS Pathways plc (CMPS) held its most recent earnings call on 2026-05-13, covering fiscal Q1 2026.
COMPASS Pathways plc (CMPS) operates in the Healthcare sector (Medical Care Facilities industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-02 | — | $-0.42 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-04 | $-0.36 | $-0.46 | +21.7% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-12 | $-0.30 | $-0.31 | +3.2% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-02-25 | $-0.61 | $-0.40 | -52.7% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-03 | $-0.38 | $-0.40 | +5.0% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-07-30 | $-0.41 | $-0.37 | -10.8% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $-0.42 | $-0.49 | +14.3% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-02-25 | $-0.63 | $-0.63 | 0.0% | $0 | — | — | EODHD |
| Q3 FY2024 | 2024-10-30 | $-0.56 | $-0.59 | +5.1% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-07-31 | $-0.56 | $-0.55 | -1.8% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-05-07 | $-0.55 | $-0.49 | -12.2% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-02-28 | $-0.53 | $-0.34 | -55.9% | $3.7M | — | — | EODHD |
| Q3 FY2023 | 2023-11-01 | $-0.67 | $-0.42 | -59.5% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-02 | $-0.62 | $-0.70 | +11.4% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-0.57 | $-0.65 | +12.3% | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-02-27 | $-0.73 | $-0.59 | -23.7% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-11-02 | $-0.43 | $-0.64 | +32.8% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-03 | $-0.50 | $-0.60 | +16.7% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-09 | $-0.50 | $-0.67 | +25.4% | $0 | — | — | EODHD |
| Q4 FY2021 | 2022-02-23 | $-0.61 | $-0.50 | -22.0% | $0 | — | — | EODHD |
Source: EODHD. CMPS reported actuals as published; sparse fields render as —.